DE LUCHTHAVEN APOTHEEK
ActiveDE LUCHTHAVEN APOTHEEK has been active since 2005 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €699k and a net result of €146k. Equity remains stable across the filed fiscal years (±1.4% per year). Its solvency ranks better than 60% of 10242 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.5% (low).
Checked score
Score 2025
94
/ 100
Excellent▲ +8 vs 2024
The score combines four axes. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability100=
Solvency91▲+12
Growth78=
Stability100
Bankruptcy probability, 12 months
0.5%
Low
0%0.5%1.5%4%10%≥ 25%
Credit up to €65k at 30 days acceptable
Liquidity ample (current ratio 2.1 against 1.77 in 2024), but 53.5% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Seven signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 47
Relative position
BE, all sectors
reference
Sector 47
higher
← fewer bankruptcies
more bankruptcies →
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
46.5%
Return on assets
9.7%
Age of the figures
8 mo
lowers risk · Growing equity
Equity grew over 2023-2025. Profits are largely retained rather than distributed.
NBB · annual accounts 2025Equity per financial year
1819202122232425
2018 to 2025 · latest year €699k
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 31-07-2026, 0 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
on the day
2024
29 d late
2023
30 d late
2022
52 d late
2021
2 d early
2020
100 d late
2019
83 d late
← before the deadline
after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
15-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, abbreviated schema
Equity
€699k▲ 26.4%
2024 · €553k
2018: €528k
2019: €503k
2020: €413k
2021: €491k
2022: €381k
2023: €413k
2024: €553k
2018 → 2025
Total assets
€1.50M▲ 8.4%
2024 · €1.39M
2018: €813k
2019: €784k
2020: €634k
2021: €789k
2022: €1.39M
2023: €1.27M
2024: €1.39M
2018 → 2025
Net result
€146k▲ 3.7%
2024 · €141k
2018: €65k
2019: €-25k
2020: €-90k
2021: €76k
2022: €119k
2023: €164k
2024: €141k
2018 → 2025
Working capital
€673k▲ 45.8%
2024 · €462k
2018: €491k
2019: €481k
2020: €411k
2021: €566k
2022: €242k
2023: €246k
2024: €462k
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Equity€491k-€381k▼ 22.5%€413k▲ 8.3%€553k▲ 34.1%€699k▲ 26.4%
Operating result€76k-€139k▲ 82.0%€242k▲ 74.6%€250k▲ 3.2%€248k▼ 0.7%
Net result€76k-€119k▲ 57.6%€164k▲ 37.4%€141k▼ 14.2%€146k▲ 3.7%
Turnover and EBIT margin not published: the abbreviated or micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result falls in 2025; 2025 is 1% below 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €1.50M
Fixed assets
€217k▼ 33.0%
Current assets
€1.29M▲ 21.0%
Equity and liabilities €1.50M
Equity
€699k▲ 26.4%
Debt
€804k▼ 3.6%
The debt ratio falls from 60.1% to 53.5%: equity grows while debt is paid down.
Key figures and ratios
EBITDA
€361k▼
2024 · €364k
Cash flow
€260k▲
2024 · €255k
Solvency
46.5%▲
2024 · 39.9%
Current ratio
2.10▲
2024 · 1.77
Quick ratio
1.26▲
2024 · 1.00
Debt / equity
1.15▼
2024 · 1.51
ROE
20.9%▼
2024 · 25.4%
ROA
9.7%▼
2024 · 10.1%
Interest coverage
11.99▲
2024 · 10.36
Debt
€804k▼
2024 · €834k
Debt ≤ 1 year
€613k▲
2024 · €601k
Debt > 1 year
€191k▼
2024 · €233k
Income taxes
€72k▼
2024 · €76k
Staff costs
€450k▲
2024 · €358k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet
Code20242025
Assets
Total assets20/58€1.39M€1.50M▲
Fixed assets21/28€324k€217k▼
Tangible fixed assets22/27€324k€217k▼
Plant, machinery and equipment23€89k€60k▼
Furniture and vehicles24€45k€34k▼
Other tangible fixed assets26€190k€124k▼
Current assets29/58€1.06M€1.29M▲
Stocks and contracts in progress3€460k€517k▲
Stocks30/36€460k€517k▲
Amounts receivable within one year40/41€292k€323k▲
Trade receivables40€57k€91k▲
Other amounts receivable41€236k€232k▼
Cash at bank and in hand54/58€306k€438k▲
Deferred charges and accrued income490/1€5k€8k▲
Equity and liabilities
Total equity and liabilities10/49€1.39M€1.50M▲
Equity10/15€553k€699k▲
Contributions10/11€12k€12k=
Reserves13€541k€687k▲
Non-distributable reserves130/1€2k€2k=
Reserves not available under the articles1311€2k€2k=
Tax-exempt reserves132€19k€19k=
Distributable reserves133€520k€666k▲
Profit (loss) carried forward14€0-
Amounts payable17/49€834k€804k▼
Amounts payable after more than one year17€233k€191k▼
Financial debts170/4€233k€191k▼
Amounts payable within one year42/48€601k€613k▲
Current portion of amounts payable after more than one year42€40k€42k▲
Financial debts43€3k€10k▲
Credit institutions430/8€3k€10k▲
Trade debts44€296k€324k▲
Suppliers440/4€296k€324k▲
Taxes, remuneration and social security45€120k€116k▼
Taxes450/3€66k€37k▼
Remuneration and social security454/9€54k€79k▲
Other amounts payable47/48€141k€122k▼
Income statement
Code20242025
Remuneration, social security and pensions62€358k€450k▲
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€115k€114k▼
Other operating charges640/8€1k€2k▲
Non-recurring operating charges66A€13k€3k▼
Gross operating margin9900€736k€816k▲
Operating profit (loss)9901€250k€248k▼
Financial income75/76B€2k€99▼
Recurring financial income75€2k€99▼
Non-recurring financial income76B€0-
Financial charges65/66B€35k€30k▼
Recurring financial charges65€35k€30k▼
Profit (loss) for the period before taxes9903€217k€218k▲
Income taxes67/77€76k€72k▼
Profit (loss) for the period9904€141k€146k▲
Profit (loss) for the period to be appropriated9905€141k€146k▲
Appropriation of the result
Profit (loss) to be appropriated9906€141k€146k▲
Transfer from equity791/2€0-
Transfer to equity691/2€141k€146k▲
To other reserves6921€141k€146k▲
Profit to be distributed694/7€0-
Return on contributions (dividend)694€0-
Social balance
Average headcount (FTE)90874.86.1▲
The notes to these accounts (13 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
31-07
NBB filing
Annual accounts filed
fiscal year 2025 · abbreviated schema
2025
29-08
NBB filing
Annual accounts filed
fiscal year 2024 · abbreviated schema · 29 days late
2024
31-12
Financial
Equity above €500kEq €553k ▲34.1%
4 profitable years in a row build equity to €553k.
30-08
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema · 30 days late
2023
31-12
Financial
Highest result since 2018net €164k ▲37.4%
Net result €164k, the highest in the series.
21-09
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema · 52 days late
2022
29-07
NBB filing
Annual accounts filed
fiscal year 2021 · abbreviated schema
2021
31-12
Financial
Back to profitnet €76k
Net result €76k after 2 loss-making years.
08-11
NBB filing
Annual accounts filed
fiscal year 2020 · abbreviated schema · 100 days late
2020
31-12
Financial
Weakest financial yearnet €-90k
Net result drops to €-90k, the lowest in the series; recovery starts the following year.
22-10
NBB filing
Annual accounts filed
fiscal year 2019 · abbreviated schema · 83 days late
2019
29-07
NBB filing
Annual accounts filed
fiscal year 2018 · abbreviated schema
2018
06-07
NBB filing
Annual accounts filed
fiscal year 2017 · micro schema
2017
20-07
NBB filing
Annual accounts filed
fiscal year 2016 · abbreviated schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
2 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Zaventem · 1 establishment unit since 2005
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Luchthaven Brussel Nationaal ZN1930 ZaventemGround area
8,564 m²
Parcel 23094A0072/00K000, Flanders. Linked by address, not a title deed.
1 establishment unit
DE LUCHTHAVEN APOTHEEK
since 20052.206.509.676
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 23094A0072/00K000 | Flanders | 8,564 m² | - | - |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Recognitions · licences · registrations
Food safety, FASFC
1 siteZaventem2.206.509.676
Similar companies · same sector, comparable size
DE BIE T.
BE 0832.636.914
Affligem · Eq €700k
APOTHEEK LEFEVER - DE CLOEDT
BE 0421.212.996
Knokke-Heist · Eq €699k
Apotheker Neyt
BE 0848.149.093
Brugge · Eq €699k
Apotheek BAKELANTS
BE 0414.500.992
Geel · Eq €700k
APOTHEEK SUYKERBUYK
BE 0448.564.919
Antwerpen · Eq €700k
Of 5,209 companies in sector 47730 we hold annual accounts for 3,851. 3,220 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company (pre-2019)
Founded13-04-2005
Fiscal year end31-12
Activities, NACEBEL
47730Retail sale of pharmaceutical products
Sources
Crossroads Bank for EnterprisesNational Bank · 20 filingsAddress and cadastre registers
Data from official sources, last processed on 15-09-2026. Scores and ratios are computed by Checked and are not a credit decision.